Durham, NC, United States of America

Rita Meganck

This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rita Meganck. Retrieved from https://idiyas.com/inventor/rita-meganck-f6ff5vil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rita Meganck: Innovator in Circular RNA Expression

Introduction

Rita Meganck is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of molecular biology, particularly in the area of circular RNA expression. Her innovative work has the potential to impact various applications in genetic research and therapeutic development.

Latest Patents

Rita Meganck holds a patent titled "Compositions and Methods for Circular RNA Expression." This patent represents her pioneering efforts in developing methods that enhance the expression of circular RNA, which is crucial for advancing our understanding of gene regulation and expression.

Career Highlights

Rita is affiliated with Duke University, where she conducts her research and contributes to the academic community. Her work at this prestigious institution has allowed her to collaborate with other leading scientists and researchers in the field.

Collaborations

Due to space constraints, the details of her collaborations will not be included.

Conclusion

Rita Meganck's contributions to the field of circular RNA expression exemplify her dedication to innovation and research. Her patent and work at Duke University highlight her role as a key figure in advancing molecular biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…